OSA symptoms more common among African-American women than Caucasians

WESTCHESTER, Ill. In a study that examined the relationship between race, menopausal status and symptoms of obstructive sleep apnea (OSA), middle-aged African-American women were found to be more likely to experience OSA symptoms than their Caucasian counterparts, according to a research abstract that will be presented Monday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

Elizabeth Beothy, of the University of Pennsylvania, who authored the study, administered a questionnaire to 269 subjects, with an average age of 48, and 49.4 percent of which were African-American. Further, 37.5 percent of women were pre-menopausal, 43 percent in the menopausal transition and 19.5 percent post-menopausal.

The mean apnea score among African-American women was nearly double that of Caucasian women. Menopausal status was not a significant predictor of OSA symptoms. Race remained a significant predictor of OSA symptoms after adjustment for current body mass index (BMI), BMI change over time and menopausal status.

"Although menopausal status did not predict OSA symptoms, OSA symptoms on our cohort of menopausal women increased with higher BMI and larger BMI increases over time," said Beothy, who added that studies to document whether OSA is more common among African-American women than Caucasian women should be performed to further investigate these findings.

OSA affects an estimated 15 million to 20 million Americans, as well as millions more who remain undiagnosed and untreated.

Scientific evidence shows that CPAP is the best treatment for sleep apnea. CPAP provides a steady stream of pressurized air to patients through a mask that they wear during sleep. This airflow keeps the airway open, preventing the pauses in breathing that characterize OSA and restoring normal oxygen levels.


Contact: Jim Arcuri
American Academy of Sleep Medicine

Page: 1

Related biology news :

1. Manganese levels increase in scrapie-infected sheep before clinical symptoms develop
2. MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation
3. Latest data shows MabThera provides significant, sustained relief from symptoms of RA
4. Gene malfunctions cause schizophrenia, depression symptoms in mice
5. Switching genes to overdrive improves muscular dystrophy symptoms in mice
6. Reversal of symptoms in an autism spectrum disorder
7. Malaria drug may treat metabolic syndromes many symptoms
8. Brain protein improves stroke symptoms in rats, even when injected after 3 days
9. Rush and UCSF found gene therapy appeared to reduce symptoms of Parkinsons by 40 percent
10. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
11. Researchers reverse Parkinsons symptoms in animal models

Post Your Comments:

(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
Cached News: